STRN4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.802400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.614600E-01
Normal-vs-Stage2
7.405600E-01
Normal-vs-Stage3
5.765000E-01
Normal-vs-Stage4
1.942840E-01
Stage1-vs-Stage2
5.465200E-01
Stage1-vs-Stage3
5.657600E-01
Stage1-vs-Stage4
1.813190E-01
Stage2-vs-Stage3
2.596600E-01
Stage2-vs-Stage4
6.789800E-01
Stage3-vs-Stage4
2.696200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.173200E-01
Normal-vs-AfricanAmerican
6.828600E-01
Normal-vs-Asian
1.983800E-01
Caucasian-vs-AfricanAmerican
8.514800E-01
Caucasian-vs-Asian
2.994200E-01
AfricanAmerican-vs-Asian
5.343600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.435200E-01
Normal-vs-Female
8.303200E-01
Male-vs-Female
6.778600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.696200E-01
Normal-vs-Age(41-60Yrs)
6.198200E-01
Normal-vs-Age(61-80Yrs)
4.182800E-01
Normal-vs-Age(81-100Yrs)
9.574200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.288600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.655800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.852000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.158600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.860800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.361400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.890200E-01
Normal-vs-Daily Drinker
5.921200E-01
Normal-vs-Weekly Drinker
5.847400E-01
Normal-vs-Occasional Drinker
4.345400E-01
Normal-vs-Social Drinker
9.989600E-01
Non Drinker-vs-Daily Drinker
9.949700E-02
Non Drinker-vs-Weekly Drinker
1.376390E-01
Non Drinker-vs-Occasional Drinker
3.691600E-02
Non Drinker-vs-Social Drinker
5.784800E-01
Daily Drinker-vs-Weekly Drinker
9.370600E-01
Daily Drinker-vs-Occasional Drinker
5.514000E-01
Daily Drinker-vs-Social Drinker
2.826200E-01
Weekly Drinker-vs-Occasional Drinker
6.574800E-01
Weekly Drinker-vs-Social Drinker
2.879800E-01
Occasional Drinker-vs-Social Drinker
1.029400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.607600E-01
Normal-vs-Grade 2
7.816800E-01
Normal-vs-Grade 3
7.101400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.940440E-01
Grade 1-vs-Grade 3
1.411610E-02
Grade 1-vs-Grade 4
8.607600E-01
Grade 2-vs-Grade 3
1.123160E-01
Grade 2-vs-Grade 4
7.816800E-01
Grade 3-vs-Grade 4
7.101400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.645600E-01
Normal-vs-NonDiabetic
6.219600E-02
Diabetic-vs-NonDiabetic
4.018000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.563800E-01
Normal-vs-NoPancreatitis
8.047200E-01
Pancreatitis-vs-NoPancreatitis
3.306200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.162600E-01
Normal-vs-N1
2.441400E-01
N0-vs-N1
6.469400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.518600E-03
Normal-vs-TP53-NonMutant
9.985700E-02
TP53-Mutant-vs-TP53-NonMutant
8.20170000026543E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
